Testing effectiveness (Phase 2)WithdrawnNCT01451450
What this trial is testing
Efficacy and Safety of 4 Doses of QGE031 in Patients 18-50 Years of Age With Peanut Allergy
Who this might be right for
Peanut Allergy
Novartis Pharmaceuticals
Showing 20 of 189 results